Honorary Senior Lecturer at Inflammation, Repair and Development Section, NHLI, St Mary's Campus.
Dr Munblit graduated from a Russian State Medical University in 2003 and then been trained at the Moscow Institute of Paediatrics and Child Surgery.
Daniel accomplished his PhD research at Imperial College London in 2016. Prior to this he successfully completed MSc in Allergy programme at Imperial College London.
His main research focus is the primary prevention of allergic disease in childhood. Investigation of human colostrum and mature breast milk immune-modulatory factors in relation to maternal health, nutrition and genotype and subsequent infant outcomes in relation to susceptibility to allergy. Later he has developed a strong interest in systematic evaluation of available evidence in paediatrics and child health.
Daniel leads The Core Outcome Measures for Food Allergy (COMFA) COST Action, approved by the EU commissioners in June 2019. This project is aiming to define the scope and applicability of food allergy Core Outcome sets and develop Core Outcome sets and measurement tools for food allergy.
Dr. Munblit is a member of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric section board and a member of Paediatric Allergy Education & Training Committee (PA-ETC) at EAACI. He chairs PARANOID EAACI Task Force aiming to assess perceptions, beliefs, attitudes, and decision making in parents of children with allergic diseases. Daniel is a member of Education & Training, Food Allergy and Allergy Prevention Committees at World Allergy Organization (WAO).
At the time of COVID-19 pandemic Daniel leads Stop COVID cohort at Sechenov University, Moscow, Russia. He is also heavily involved in International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) post-covid condition research co-leading ISARIC Global COVID-19 paediatric follow-up. Daniel also co-leads an initiative aiming to establish Core Outcome Set for post-covid condition.
Dr. Munblit shares his time between London and Moscow. He is a Professor at the Department of Paediatrics and Infectious Diseases at Sechenov University.
Apart from research activities, Daniel is lecturing at MSc in Paediatrics and MSc in Allergy courses and supervising students at Imperial College London and Sechenov University.
et al., 2021, Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19, Clinical and Experimental Allergy, ISSN:0954-7894
et al., 2021, Treatment of multisystem inflammatory syndrome in children, New England Journal of Medicine, Vol:385, ISSN:0028-4793, Pages:11-22
et al., 2021, Risk factors for long covid in previoulsy hospitalsied children using the ISARIC Global Follow-Up Protocol: a prospective cohort study, European Respiratory Journal, ISSN:0903-1936
et al., 2021, StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection, Clinical Infectious Diseases, Vol:73, ISSN:1058-4838, Pages:1-11
ISARIC Clinical Characterisation Group, 2021, COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study, Infection: Journal of Infectious Disease, ISSN:0300-8126